NIH supports Arteriocyte stem cell expansion technology development
The grant will allow Arteriocyte to develop Nanex platform to be used in stem cell transplants, a procedure often performed for leukemia or multiple myeloma patients. Arteriocyte’s collaborators
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.